Skip to main content
Erschienen in: Inflammation 3/2023

13.02.2023 | ORIGINAL ARTICLE

Risk of Early Infection in Idiopathic Inflammatory Myopathies: Cluster Analysis Based on Clinical Features and Biomarkers

verfasst von: Lu Cheng, Yanhong Li, Yinlan Wu, Yubin Luo, Yu Zhou, Zehui Liao, Ji Wen, Xiuping Liang, Tong Wu, Chunyu Tan, Yi Liu

Erschienen in: Inflammation | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Patients with idiopathic inflammatory myopathies (IIMs), referred to as myositis, are prone to infectious complications, which hinder the treatment of the disease and worsen the outcome of patients. The purpose of this study was to explore the different types of infectious complications in patients with myositis and to determine the predisposing factors for clinical reference. A retrospective study was conducted on 66 patients with IIM who were divided into different subpopulations by an unsupervised analysis of their clinical manifestations, laboratory features, and autoantibody characteristics. Combined with the incidence of infectious complications, the types of infectious pathogens and the sites of infection, the characteristics of infection, and susceptibility factors were explored. Three clusters with significantly different clinical characteristics and coinfection rates were identified (76.2% vs. 41.6% vs. 36.4%, p = 0.0139). Cluster 1 (n = 12) had a moderate risk of infection, with an infection rate of 41.6%. The patients in cluster 1 had a high probability of positive mechanic’s hands, periungual erythema, anti-Ro52 antibody, and anti-Jo1 antibody. CD3 and CD4 were the highest among the three groups. Cluster 2 (n = 21) had a high risk of infection, and the incidence of infection was 76.2%. Almost all patients in this cluster had a rash, prominent clinical symptoms, and decreased WBC, PMN, LYM, CD3, and CD4 counts. Cluster 3 (n = 33) had a low risk of infection, with an infection rate of 36.4%. Compared with the other two clusters, cluster 3 (n = 33) lacked a typical rash but had a high ANA-positive rate. The patients in cluster 1 and cluster 3 were mainly infected by viruses, followed by bacterial infections. In cluster 2 patients, bacterial infections were the most prevalent. Fungal and Pneumocystis carinii were common causes of cluster 2 and 3 infections. In addition, the patients within a cluster often have a single infection, and pulmonary infections are the most common. We clustered the patients with IIM complicated with infection into three different types by their clinical symptoms and found that there were differences in the infection risk and infection types among the different cluster groups.
Literatur
6.
Zurück zum Zitat Redondo-Benito, A., A. Curran, A. Villar-Gomez, E. Trallero-Araguas, A. Fernández-Codina, I. Pinal-Fernandez, J.Á. Rodrigo-Pendás, and A. Selva-O’Callaghan. 2018. Opportunistic infections in patients with idiopathic inflammatory myopathies. International Journal of Rheumatic Diseases 21 (2): 487–496. https://doi.org/10.1111/1756-185X.13255.CrossRefPubMed Redondo-Benito, A., A. Curran, A. Villar-Gomez, E. Trallero-Araguas, A. Fernández-Codina, I. Pinal-Fernandez, J.Á. Rodrigo-Pendás, and A. Selva-O’Callaghan. 2018. Opportunistic infections in patients with idiopathic inflammatory myopathies. International Journal of Rheumatic Diseases 21 (2): 487–496. https://​doi.​org/​10.​1111/​1756-185X.​13255.CrossRefPubMed
8.
Zurück zum Zitat Bohan, A., and J.B. Peter. 1975. Polymyositis and dermatomyositis (first of two parts) (J). New England Journal of Medicine 292 (7): 344–347.CrossRefPubMed Bohan, A., and J.B. Peter. 1975. Polymyositis and dermatomyositis (first of two parts) (J). New England Journal of Medicine 292 (7): 344–347.CrossRefPubMed
13.
Zurück zum Zitat Miró, O., M. Laguno, J.R. Alonso, J. Casademont, C. Herrero, A. Selva, A. Urbano-Márquez, and J.M. Grau. 1999. Evolución de las miopatías inflamatorias idiopáticas: complicaciones, supervivencia y factores pronósticos Clinical course of idiopathic inflammatory myopathies: complications, survival and prognostic factors. Medicina Clínica 112 (14): 521–6. Spanish. PMID: 10363237 Miró, O., M. Laguno, J.R. Alonso, J. Casademont, C. Herrero, A. Selva, A. Urbano-Márquez, and J.M. Grau. 1999. Evolución de las miopatías inflamatorias idiopáticas: complicaciones, supervivencia y factores pronósticos Clinical course of idiopathic inflammatory myopathies: complications, survival and prognostic factors. Medicina Clínica 112 (14): 521–6. Spanish. PMID: 10363237
19.
Zurück zum Zitat Feng, M., H. Guo, C. Zhang, C. Wang, Z. Liang, X. Zhao, Y. Qin, Y. Wu, G. Liu, C. Gao, and J. Luo. 2019. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis. International Immunopharmacology 77: 105912. https://doi.org/10.1016/j.intimp.2019.105912 Feng, M., H. Guo, C. Zhang, C. Wang, Z. Liang, X. Zhao, Y. Qin, Y. Wu, G. Liu, C. Gao, and J. Luo. 2019. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis. International Immunopharmacology 77: 105912. https://​doi.​org/​10.​1016/​j.​intimp.​2019.​105912
20.
Zurück zum Zitat Arning, M., and C. Aul. 1994. Mykose-Prophylaxe bei neutrozytopenischen Patienten [Prophylaxis against mycoses in neutropenic patients]. Mycoses 37 Suppl 2: 70–6. German Arning, M., and C. Aul. 1994. Mykose-Prophylaxe bei neutrozytopenischen Patienten [Prophylaxis against mycoses in neutropenic patients]. Mycoses 37 Suppl 2: 70–6. German
23.
Zurück zum Zitat Marie, I., E. Hachulla, and P. Che´rin, et al. 2005. Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheumatoid 53: 155–65, Infections in polymyositis and dermatomyositis: analysis of 192 cases Marie, I., E. Hachulla, and P. Che´rin, et al. 2005. Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheumatoid 53: 155–65, Infections in polymyositis and dermatomyositis: analysis of 192 cases
24.
Zurück zum Zitat Huang, L., W. Zhu, Y. Ye, X. Wu, Q. Yan, Z. Wang, Y. Lin, and S. Chen. 2021. Association of cytomegalovirus infection with anti-MDA5 antibody-positive dermatomyositis: a prospective cohort study. Frontiers in Medicine (Lausanne) 8: 740154. https://doi.org/10.3389/fmed.2021.740154 Huang, L., W. Zhu, Y. Ye, X. Wu, Q. Yan, Z. Wang, Y. Lin, and S. Chen. 2021. Association of cytomegalovirus infection with anti-MDA5 antibody-positive dermatomyositis: a prospective cohort study. Frontiers in Medicine (Lausanne) 8: 740154. https://​doi.​org/​10.​3389/​fmed.​2021.​740154
26.
Zurück zum Zitat Haldule, S., M. Chatterjee, R.P. Goswami, I. Vadsaria, P. Gaur, C. Kavadichanda, D.P. Misra, H. Chinoy, V. Agarwal, R. Aggarwal, and L. Gupta. 2022. A systematic review and meta-analysis of mycobacterial infections in patients with idiopathic inflammatory myopathies. Rheumatology (Oxford) 61 (9): 3521–3533. https://doi.org/10.1093/rheumatology/keac041.CrossRefPubMed Haldule, S., M. Chatterjee, R.P. Goswami, I. Vadsaria, P. Gaur, C. Kavadichanda, D.P. Misra, H. Chinoy, V. Agarwal, R. Aggarwal, and L. Gupta. 2022. A systematic review and meta-analysis of mycobacterial infections in patients with idiopathic inflammatory myopathies. Rheumatology (Oxford) 61 (9): 3521–3533. https://​doi.​org/​10.​1093/​rheumatology/​keac041.CrossRefPubMed
Metadaten
Titel
Risk of Early Infection in Idiopathic Inflammatory Myopathies: Cluster Analysis Based on Clinical Features and Biomarkers
verfasst von
Lu Cheng
Yanhong Li
Yinlan Wu
Yubin Luo
Yu Zhou
Zehui Liao
Ji Wen
Xiuping Liang
Tong Wu
Chunyu Tan
Yi Liu
Publikationsdatum
13.02.2023
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01790-w

Weitere Artikel der Ausgabe 3/2023

Inflammation 3/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.